Bortezomib, Combination Chemotherapy, and Rituximab as First-Line Therapy in Treating Patients With Stage III or Stage IV Follicular Non-Hodgkin's Lymphoma
Clinical trial NCT00428142 · COMPLETED
Trial details
- NCT number
- NCT00428142
- Sponsor
- NCIC Clinical Trials Group
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-05-01
- Primary completion
- 2011-04-01
- Enrollment
- 95
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.